Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · Real-Time Price · USD
13.32
+0.09 (0.68%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Surgery Partners Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,728 | 1,985 | 2,676 | 4,015 | 3,370 | 4,694 | |
Market Cap Growth | -36.39% | -25.82% | -33.36% | 19.14% | -28.22% | 225.45% |
Enterprise Value | 5,578 | 7,490 | 7,610 | 8,095 | 8,056 | 8,742 |
Last Close Price | 13.32 | 15.45 | 21.17 | 31.99 | 27.86 | 53.41 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | 51.23 | 24.93 | 23.31 | 35.08 | 58.71 | 183.86 |
PS Ratio | 0.51 | 0.60 | 0.86 | 1.46 | 1.33 | 2.11 |
PB Ratio | 1.03 | 0.56 | 0.74 | 1.19 | 1.03 | 2.04 |
P/FCF Ratio | 9.21 | 10.15 | 12.76 | 19.58 | 43.09 | 159.12 |
P/OCF Ratio | 6.70 | 7.24 | 8.91 | 13.67 | 21.22 | 53.89 |
PEG Ratio | 3.91 | 0.27 | 4.09 | 4.09 | 4.09 | 4.09 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.66 | 2.26 | 2.44 | 2.95 | 3.17 | 3.93 |
EV/EBITDA Ratio | 8.63 | 11.43 | 12.14 | 15.16 | 16.38 | 21.70 |
EV/EBIT Ratio | 11.89 | 15.62 | 16.05 | 19.46 | 21.37 | 28.75 |
EV/FCF Ratio | 29.73 | 38.29 | 36.29 | 39.49 | 103.01 | 296.34 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.17 | 1.15 | 1.02 | 0.92 | 0.91 | 1.46 |
Debt / EBITDA Ratio | 5.51 | 5.43 | 5.18 | 4.97 | 5.17 | 6.79 |
Debt / FCF Ratio | 21.68 | 20.65 | 17.71 | 15.02 | 37.98 | 113.65 |
Net Debt / Equity Ratio | 1.11 | 1.08 | 0.94 | 0.86 | 0.82 | 1.29 |
Net Debt / EBITDA Ratio | 5.96 | 5.80 | 5.48 | 5.40 | 5.47 | 7.35 |
Net Debt / FCF Ratio | 20.52 | 19.42 | 16.37 | 14.07 | 34.36 | 100.43 |
Asset Turnover | 0.42 | 0.41 | 0.42 | 0.41 | 0.40 | 0.39 |
Inventory Turnover | 28.03 | 27.50 | 28.96 | 28.59 | 29.65 | 29.51 |
Quick Ratio | 1.44 | 1.37 | 1.38 | 1.32 | 1.50 | 1.53 |
Current Ratio | 1.95 | 1.87 | 1.79 | 1.71 | 1.87 | 1.76 |
Return on Equity (ROE) | 2.32% | 2.76% | 0.36% | 4.07% | 3.12% | 3.60% |
Return on Assets (ROA) | 3.66% | 3.74% | 4.01% | 3.84% | 3.68% | 3.30% |
Return on Invested Capital (ROIC) | 5.12% | 5.64% | 0.60% | 6.81% | 5.29% | 5.39% |
Return on Capital Employed (ROCE) | 6.30% | 6.40% | 6.50% | 6.50% | 6.10% | 5.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -5.13% | -3.92% | -6.28% | -0.30% | -1.62% | -1.51% |
FCF Yield | 10.86% | 9.86% | 7.84% | 5.11% | 2.32% | 0.63% |
Buyback Yield / Dilution | -1.28% | -0.86% | -0.40% | -36.61% | -26.96% | -48.49% |